Medication study for relapsing polychondritis
Treatments studied
Part of Bones, joints & muscles, Heart & circulation, Skin clinical trials.
This trial tests if a type of medication that adjusts the immune system can help control symptoms of relapsing polychondritis. It is for people with mild to moderate active disease that needs more treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with relapsing polychondritis using standard criteria.
- You have had mild to moderate active disease symptoms in the last 60 days that need a higher dose of prednisone (20-60 mg per day).
- You are willing to use effective birth control if you or your partner can have children.
- You have not used certain stronger immune-suppressing drugs (biologics) before.
- You do not have severe organ-threatening disease or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have been diagnosed with relapsing polychondritis over time. It aims to better understand the condition and how it progresses, which may help future care.
This trial tests whether upadacitinib, an oral medication, is safe and effective for people with relapsing polychondritis that hasn't improved enough with standard treatments. It aims to reduce inflammation and control symptoms.
This trial tests two ways of managing your immunosuppressant medication around the time of shoulder replacement surgery. The goal is to see if one approach leads to fewer infections while still controlling your rheumatic disease.
This study tests a new medication called AZD1163 for people with rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if the drug can safely reduce joint swelling and pain.
This trial tests different targeted treatments for people with rheumatoid arthritis who have tried one or two biologic or targeted synthetic drugs but still have symptoms. You need to be taking a stable dose of methotrexate.
This trial studies rheumatoid arthritis (RA) patients starting or adjusting DMARD medicines and looks for signs that predict who responds best. It may help doctors choose more effective treatment sooner.
Hear when a new Relapsing Polychondritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.